(Q73145891)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Immunogenicity and safety of a liquid combination of DTP-PRP-T [corrected] vs lyophilized PRP-T reconstituted with DTP (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Amir

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Melamed

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Bader

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Ethevenaux

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

B Fritzell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J R Cartier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F Arminjon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Dagan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

149-154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900162-4

7 January 2021

Characterization of the serum antibody response induced by Haemophilus influenzae type b tetanus protein-conjugate vaccine in infants receiving a DTP-combined vaccine from 2 months of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900162-4

7 January 2021

Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900162-4

7 January 2021

Safety and immunogenicity of acellular diphtheria-tetanus-pertussis and Haemophilus conjugate vaccines given in combination or at separate injection sites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900162-4

7 January 2021

Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900162-4

7 January 2021

Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900162-4

7 January 2021

Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. The Kaiser Permanente Pediatric Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900162-4

7 January 2021

A quantitative immunochemical measure of the primary interaction between I BSA and antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900162-4

7 January 2021

Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900162-4

7 January 2021

10.1016/S0264-410X(96)00162-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9066031%20AND%20SRC:MED&resulttype=core&format=json